Clinical and Vaccine Immunology, March 2006, p. 309-313, Vol. 13, No. 3
1071-412X/06/$08.00+0 doi:10.1128/CVI.13.3.309-313.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Hye Jin Kim,1,
Young Hee Ryu,1
Cheol-Heui Yun,1
Dae Kyun Chung,3,4 and
Seung Hyun Han1*
International Vaccine Institute, Seoul 151-600, Republic of Korea,1 Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejon 305-701, Republic of Korea,2 School of Biotechnology and Institute of Life Science and Resources, Kyung Hee University, Suwon 449-701, Republic of Korea,3 RNA Inc., Suwon 449-701, Republic of Korea4
Received 8 September 2005/ Returned for modification 23 November 2005/ Accepted 28 December 2005
Commercially available pokeweed mitogen (PWM) has been reported to activate macrophages, leading to production of proinflammatory cytokines and nitric oxide (NO). However, we found that polymyxin B (PMB), a specific inhibitor of endotoxin activity, inhibited the PWM-induced expression of proinflammatory cytokines and NO and the activation of Toll-like receptor 4 (TLR4). A kinetic-turbidimetric Limulus amebocyte lysate assay demonstrated that commercial PWM contained substantial endotoxin, over 104 endotoxin units/mg of the PWM. A PWM repurified by PMB-coupled beads no longer induced the expression of proinflammatory cytokines, TLR4 activation, or dendritic cell maturation. However, the repurified PWM remained able to induce proliferation of human lymphocytes, which is a representative characteristic of PWM. These results suggest that commercial PWM might be contaminated with a large amount of endotoxin, resulting in the attribution of misleading immunological properties to PWM.
J.S.Y. and H.J.K. contributed equally to this study.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |